메뉴 건너뛰기
Hypertension
Volumn 55, Issue 3, 2010, Pages
"Effective" plasma renin activity: A derived measure for assessing residual plasma renin activity in patients taking angiotensin- converting enzyme inhibitors or angiotensin receptor blockers
Author keywords

[No Author keywords available]
Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE; DIURETIC AGENT; RENIN; RENIN INHIBITOR;
EID: 77149177058     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.109.148023     Document Type: Letter
Times cited : (18)
References (4)
  • 1
    • 34247644329 scopus 로고    scopus 로고
    • Aliskiren, the first renin inhibitor for treating hypertension: Reactive renin secretion may limit its effectiveness
    • Sealey JE, Laragh JH. Aliskiren, the first renin inhibitor for treating hypertension: reactive renin secretion may limit its effectiveness. Am J Hypertens. 2007;20:587-597.
    • (2007) Am J Hypertens , vol.20 , pp. 587-597
    • Sealey, J.E.1    Laragh, J.H.2
  • 2
    • 69249131743 scopus 로고    scopus 로고
    • Using plasma renin (PRA) testing to design follow up drug treatment strategies in hypertensive patients already taking antirenin drugs
    • Sealey JE, Laragh JH. Using plasma renin (PRA) testing to design follow up drug treatment strategies in hypertensive patients already taking antirenin drugs. Am J Hypertens. 2009;22:950-950
    • (2009) Am J Hypertens , vol.22 , pp. 950-950
    • Sealey, J.E.1    Laragh, J.H.2
  • 3
    • 28144458569 scopus 로고    scopus 로고
    • Sustained 24-hour blockade of the renin-angiotensin system: A high dose of a long-acting blocker is as effective as a lower dose combined with an angioten-sin-converting enzyme inhibitor
    • Hasler CJN, Maillard M, Forclaz A, Brunner HR, Burnier M. Sustained 24-hour blockade of the renin-angiotensin system: a high dose of a long-acting blocker is as effective as a lower dose combined with an angioten-sin-converting enzyme inhibitor. Clin Pharmacol Ther. 2005;78:501-507.
    • (2005) Clin Pharmacol Ther , vol.78 , pp. 501-507
    • Hasler, C.J.N.1    Maillard, M.2    Forclaz, A.3    Brunner, H.R.4    Burnier, M.5
  • 4
    • 70349249634 scopus 로고    scopus 로고
    • Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: Results from a randomized trial
    • Pimenta E, Gaddam KK, Oparil S, Aban I, Husain S, Dell'Italia LJ, Calhoun DA. Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial. Hypertension. 2009;54:475-481.
    • (2009) Hypertension , vol.54 , pp. 475-481
    • Pimenta, E.1    Gaddam, K.K.2    Oparil, S.3    Aban, I.4    Husain, S.5    Dell'Italia, L.J.6    Calhoun, D.A.7

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.